Regenxbio (RGNX) Gross Margin Growth (1y) (2015 - 2024)
Powered by 
Analysis
Regenxbio (RGNX) Gross Margin Growth (1y) (2015 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -93.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -91.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 210.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 1,966.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 228.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -475.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1,034.00 |
| 10 | Regenxbio | 472.74 Mn | 367.22 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 2,081.00 |
| Sep 30, 2024 | -835.00 |
| Jun 30, 2024 | -2.00 |
| Mar 31, 2024 | -593.00 |
| Dec 31, 2023 | -981.00 |
| Sep 30, 2023 | 654.00 |
| Jun 30, 2023 | -776.00 |
| Mar 31, 2023 | 4,925.00 |
| Dec 31, 2022 | -3,500.00 |
| Sep 30, 2022 | -355.00 |
| Jun 30, 2022 | 489.00 |
| Mar 31, 2022 | -4,505.00 |
| Dec 31, 2021 | 4,205.00 |
| Sep 30, 2021 | -2,828.00 |
| Jun 30, 2021 | -1,629.00 |
| Mar 31, 2021 | -637.00 |
| Dec 31, 2020 | -1,561.00 |
| Sep 30, 2020 | -59.00 |
| Jun 30, 2020 | -382.00 |
| Mar 31, 2020 | -1,604.00 |